INS and diabetes mellitus: ALA has insulin-mimetic and anti-inflammatory activities (175), which increase insulin sensitivity (176), prevent retinal lipid peroxidation in early diabetes (177), inhibit the activation of NF-κB induced by late glycosylation end products in endothelial cells (178), and inhibit apoptosis in retinal capillary cells (179), thereby controlling the development of DR.